Cancer Metabolism: Current Understanding and Therapies

被引：168
作者：
Counihan, Jessica L. [1 ,2 ,3 ,4 ]
Grossman, Elizabeth A. [1 ,2 ,3 ,4 ]
Nomura, Daniel K. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA
[4] Univ Calif Berkeley, Dept Toxicol, Berkeley, CA 94720 USA
来源：
CHEMICAL REVIEWS | 2018年 / 118卷 / 14期
基金：
美国国家卫生研究院; 美国国家科学基金会;
关键词：
FATTY-ACID SYNTHASE; COA-CARBOXYLASE-ALPHA; PROTEIN; 90; INHIBITOR; ATP CITRATE LYASE; CELL LUNG-CANCER; INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; GERANYLGERANYLTRANSFERASE-I INHIBITORS; ORNITHINE-DECARBOXYLASE ACTIVITY; ACUTE LYMPHOBLASTIC-LEUKEMIA; INTRACELLULAR FOLATE POOLS;
D O I：
10.1021/acs.chemrev.7b00775
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Dysregulation of cancer cell metabolism contributes to abnormal cell growth, the biological end point of cancer. We review here numerous affected oncogenes and metabolic pathways common in cancer and how they contribute to cancer pathogenesis and malignancy. This review also discusses various pharmacological manipulations that take advantage of these metabolic abnormalities and the current targeted therapies that have arisen from this research.
引用
收藏
页码：6893 / 6923
页数：31
相关论文
共 412 条
  • [1] Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling
    Adam, Julie
    Hatipoglu, Emine
    O'Flaherty, Linda
    Ternette, Nicola
    Sahgal, Natasha
    Lockstone, Helen
    Baban, Dilair
    Nye, Emma
    Stamp, Gordon W.
    Wolhuter, Kathryn
    Stevens, Marcus
    Fischer, Roman
    Carmeliet, Peter
    Maxwell, Patrick H.
    Pugh, Chris W.
    Frizzell, Norma
    Soga, Tomoyoshi
    Kessler, Benedikt M.
    El-Bahrawy, Mona
    Ratcliffe, Peter J.
    Pollard, Patrick J.
    [J]. CANCER CELL, 2011, 20 (04) : 524 - 537
  • [2] Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction
    Al-Wahab, Zaid
    Mert, Ismail
    Tebbe, Calvin
    Chhina, Jasdeep
    Hijaz, Miriana
    Morris, Robert T.
    Ali-Fehmi, Rouba
    Giri, Shailendra
    Munkarah, Adnan R.
    Rattan, Ramandeep
    [J]. ONCOTARGET, 2015, 6 (13) : 10908 - 10923
  • [3] ALLEGRA CJ, 1986, J BIOL CHEM, V261, P6478
  • [4] From Krebs to clinic: glutamine metabolism to cancer therapy
    Altman, Brian J.
    Stine, Zachary E.
    Dang, Chi V.
    [J]. NATURE REVIEWS CANCER, 2016, 16 (10) : 619 - 634
  • [5] Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas
    Amar, Laurence
    Baudin, Eric
    Burnichon, Nelly
    Peyrard, Severine
    Silvera, Stephane
    Bertherat, Jerome
    Bertagna, Xavier
    Schlumberger, Martin
    Jeunemaitre, Xavier
    Gimenez-Roqueplo, Anne-Paule
    Plouin, Pierre-Francois
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (10) : 3822 - 3828
  • [6] Serine and glycine metabolism in cancer
    Amelio, Ivano
    Cutruzzola, Francesca
    Antonov, Alexey
    Agostini, Massimiliano
    Melino, Gerry
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2014, 39 (04) : 191 - 198
  • [7] Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
    Anastasiou, Dimitrios
    Yu, Yimin
    Israelsen, William J.
    Jiang, Jian-Kang
    Boxer, Matthew B.
    Hong, Bum Soo
    Tempel, Wolfram
    Dimov, Svetoslav
    Shen, Min
    Jha, Abhishek
    Yang, Hua
    Mattaini, Katherine R.
    Metallo, Christian M.
    Fiske, Brian P.
    Courtney, Kevin D.
    Malstrom, Scott
    Khan, Tahsin M.
    Kung, Charles
    Skoumbourdis, Amanda P.
    Veith, Henrike
    Southall, Noel
    Walsh, Martin J.
    Brimacombe, Kyle R.
    Leister, William
    Lunt, Sophia Y.
    Johnson, Zachary R.
    Yen, Katharine E.
    Kunii, Kaiko
    Davidson, Shawn M.
    Christofk, Heather R.
    Austin, Christopher P.
    Inglese, James
    Harris, Marian H.
    Asara, John M.
    Stephanopoulos, Gregory
    Salituro, Francesco G.
    Jin, Shengfang
    Dang, Lenny
    Auld, Douglas S.
    Park, Hee-Won
    Cantley, Lewis C.
    Thomas, Craig J.
    Heiden, Matthew G. Vander
    [J]. NATURE CHEMICAL BIOLOGY, 2012, 8 (10) : 839 - 847
  • [8] Andrew Brenner J.I., First-in-human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640 as monotherapy or in combination - final results of dose escalation
  • [9] [Anonymous], 2014, NAT COMMUN
  • [10] A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets
    Arsham, AM
    Howell, JJ
    Simon, MC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) : 29655 - 29660
12345678910